Azithromycin, a questionable treatment for COVID-19

Saved in:
Bibliographic Details
Published in:International journal of antimicrobial agents 2021-03, Vol.57 (3), p.106280-106280, Article 106280
Main Authors: Belfaqeeh, O., Janapala, R.N., Patel, J., Alhashmi, A., Pourmand, A.
Format: Article
Language:English
Subjects:
Azithromycin - therapeutic use
COVID-19 - drug therapy
Drug Combinations
Drug Therapy, Combination
Humans
Hydroxychloroquine - therapeutic use
Letter to the Editor
Lopinavir - therapeutic use
Methylprednisolone - therapeutic use
Ritonavir - therapeutic use
SARS-CoV-2 - drug effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0924-8579
1872-7913
DOI:10.1016/j.ijantimicag.2021.106280